Company page

Genmab A/s

Genmab A/S is a public biotechnology company based in Denmark, trading under the ticker GMAB. The company focuses on the development of differentiated antibody therapeutics for the treatment of cancer and other diseases. With a market capitalization of approximately 14.86 billion USD, Genmab is recognized for its innovative approach in the biopharmaceutical industry.